Skip to main content
PLB-1001 CAS#: 1440964-89-5
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data

Identification

Product NamePLB-1001IUPAC Name6-(1-cyclopropylpyrazol-4-yl)-3--triazolopyridazineMolecular StructureCAS Registry Number 1440964-89-5SynonymsBozitinib1440964-89-5VebreltinibPLB-1001APL-101Bozitinib (PLB-1001)Vebreltinib 6-(1-cyclopropylpyrazol-4-yl)-3--triazolopyridazineCBT-101CBI-31032WZP8A9VFN1,2,4-Triazolo(4,3-b)pyridazine, 6-(1-cyclopropyl-1H-pyrazol-4-yl)-3-(difluoro(6- fluoro-2-methyl-2H-indazol-5-yl)methyl)-5-{triazolopyridazin-3-yl]difluoromethyl}-6-fluoro-2-methyl-2H-indazole6-(1-Cyclopropyl-1H-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2H-indazol-5- yl)methyl)-1,2,4-triazolo(4,3-b)pyridazine6-(1-Cyclopropyl-1H-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2H-indazol-5-yl)methyl)-triazolopyridazineUNII-2WZP8A9VFNVEBRELTINIB VEBRELTINIB CHEMBL4650443SCHEMBL15594471GTPL11677PLB1001QHXLXUIZUCJRKV-UHFFFAOYSA-NBDBM107096EX-A5644s6762WHO 11677AKOS040732634MS-27454HY-125017CS-0088607G16990US9695175, 44A937089PLB-1001;T-101; APL-101; CBI-3103Molecular FormulaC20H15F3N8Molecular Weight424.4InChIInChI=1S/C20H15F3N8/c1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13/h4-10,13H,2-3H2,1H3InChI KeyQHXLXUIZUCJRKV-UHFFFAOYSA-NIsomeric SMILESCN1C=C2C=C(C(=CC2=N1)F)C(C3=NN=C4N3N=C(C=C4)C5=CN(N=C5)C6CC6)(F)F

Patent InformationPatent IDTitlePublication DateWO2022/226168DIAGNOSTIC AND TREATMENT OF CANCER USING C-MET INHIBITOR2022WO2021/222045NOVEL PHARMACEUTICAL FORMULATION FOR C-MET INHIBITOR2021WO2019/161320CANCER TREATMENT USING COMBINATION OF NEUTROPHIL MODULATOR WITH MODULATOR OF IMMUNE CHECKPOINT2019WO2014/32498HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS2014

Physical Data

Melting Point, °C 203221.16

Spectra

Route of Synthesis (ROS)

ConditionsYieldWith methanesulfonic acid; 1-methoxy-2-propanol In methanol at 90℃; for 16h;Experimental Procedure44 Example 44 : 6-(l-Cyclopropyl-lH-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-inethyl-(2H- indazol-5-yl)methyl)-triazolopyridazineGeneral procedure: Example 44 : 6-(l-Cyclopropyl-lH-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-inethyl-(2H- indazol-5-yl)methyl)-triazolopyridazine To a 100 n L round bottom flask is added l-methoxy-2-propanol (15 n L), methyl sulfonic acid (0.898 g, 9.4 mmol), 2,2-difluoro-2-(6-fluoro-2-methyl-2H-indazol-5-yl) acetohydrazide (2.01 g, 7.8 mmol), and 3-chloro-6-(l-cyclopropyl-lH-pyrazol-4-yl) pyridazine (1.81 g, 8.2 mmol). The reaction mixture is stirred at 90 °C for 16 hr. After removal of solvent, the residue is purified on a silica gel flash chromatography with methanol/dichloromethane (1 :20) to yield a light yellow solid (1.32 g, 40% yield). (MS: 425)40%

Safety and Hazards

GHS Hazard Statements

Other Data

HS CodeStorageStore at -20°C and away from lightShelf Life2 yearsMarket Price

DruglikenessLipinski rules componentMolecular Weight424.388logP5.934HBA8HBD0Matching Lipinski Rules3Veber rules componentPolar Surface Area (PSA)78.72Rotatable Bond (RotB)4Matching Veber Rules2

Use PatternPLB-1001 CAS#: 1440964-89-5 is a receptor tyrosine kinase inhibitor targeting the cell-mesenchymal-epithelial transition factor (c-MET), capable of inhibiting the proliferation of tumor cells with elevated c-MET expression. This drug can penetrate the blood-brain barrier and has been registered for 8 clinical trials domestically, with indications including non-small cell lung cancer (NSCLC), gliomas, and more.
https://www.chemwhat.com/plb-1001-cas-1440964-89-5/

Comments

Post a Comment

Popular posts from this blog

Overcoming the "Choke Points" in Semaglutide Side Chain Synthesis with Core Technologies to Enable Efficient GLP-1 Drug Manufacturing

Semaglutide, a groundbreaking product in the GLP-1 drug class, owes its extended half-life and enhanced receptor affinity largely to its unique side chain, Ste-Glu-AEEA-AEEA-OSU (CAS: 1169630-40-3) . This side chain covalently modifies the peptide backbone, significantly improving pharmacokinetics and therapeutic performance. However, its complex structure presents two critical synthetic challenges: Precise Assembly of Repetitive AEEA Units: The side chain features consecutive AEEA (aminoethoxyethoxyacetic acid) units, which require stepwise coupling via highly activated intermediates (e.g., AEEA-AEEA). Any impurities or deviations compromise downstream reaction efficiency and may trigger irreversible byproducts. Stereochemistry and Stability of Glutamic Acid (Glu): The glutamic acid component must maintain strict L-configuration, and its carboxyl groups require directional protection (e.g., OtBu) to preserve biological activity. Leveraging deep expertise in peptide chemistry a...
Post a Comment
Read more
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data Identification Product NameBCTA-4NH2IUPAC NameMolecular StructureCAS Registry Number 2559708-42-6Synonyms4,4',4",4"'-(-3,3',6,6'-tetrayl)tetraanilineMolecular FormulaC48H36N6Molecular Weight696.86 Physical Data AppearanceYellow to white powder Spectra No data available BCTA-4NH2 CAS#：2559708-42-6 NMR Route of Synthesis (ROS) No data available Safety and Hazards No data available Other Data TransportationStore at 2-8°C away from light for long time storageStore at 2-8°C away from light for long time storageHS CodeStorageStore at 2-8°C away from light for long time storageShelf Life1 yearMarket Price Toxicity/Safety PharmacologyQuantitative Results Use PatternBCTA-4NH2 CAS#: 2559708-42-6 is an organic compound with a wide range of applications. One of its primary uses is in the field of organic electronics, where it is used as a hole-transport material in organic light-emitti...
Post a Comment
Read more

Watson Chem: Pioneering Advanced Semiconductor Materials for a Sustainable Future

In today’s rapidly advancing technological landscape, the innovation of materials science is driving progress across various high-tech sectors. As a R&D platform of Watson International, Watson Chem has positioned itself at the forefront of semiconductor materials development, becoming a trusted partner for leading global research institutions, energy companies, and high-tech firms. By focusing on extreme purity and stability, Watson Chem specializes in creating cutting-edge semiconductor materials that underpin the breakthrough technologies of tomorrow. Core Competency: Extreme Purity and Stability Watson Chem’s semiconductor materials encompass a range of ultra-pure elements, oxides, sulfides, tellurides, selenides, antimonides, and other semiconductor compounds, available in purity levels ranging from 3N to 7N and beyond. These materials meet the stringent requirements of the most advanced research fields, providing the solid foundation needed for breakthrough innovations. Tru...
Post a Comment
Read more